Medical imaging provides a window into the vast, mysterious terrain of the human body.
It can reveal the health of a beating heart, detect a blockage within the body’s 60,000 miles of vessels and arteries, and illuminate a single nerve. Imaging shows us possibilities. It is what allows us to pinpoint, diagnose and treat.
MEDRAD is a market leader in computed tomography, magnetic resonance imaging, and interventional cardiology. Every day, MEDRAD products help to reveal possibilities for thousands of physicians and their patients.
Our performance is a result of unrelenting commitment to improving healthcare, to upholding standards of excellence, and to responsible activities for the benefit of our customers, shareholders, employees, and communities.
Our promise to deliver unequaled reliability and trust in our products, people, and services can be summed up in a simple, yet powerful phrase – Performance. For life.
MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company’s world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care.